Singapore HSA Medical Device Registration & SHARE Portal Consultant

Navigate Singapore's HSA regulatory framework with confidence. NexorTest Technologies provides end-to-end medical device registration consulting — from risk classification and Dealer's Licence through SHARE portal submission and post-market surveillance — for Class A through Class D devices, IVDs, and SaMD.

Free Singapore Assessment

Get a personalised regulatory roadmap in 24 hours

Full Name *

Business Email *

Device Class *

Dealer Type *

No obligation. Response within 24 hours.

HSA Classification Pathways

Four Risk-Based Device Classes Under Health Products Act

HSA classifies all medical devices into four risk categories aligned with GHTF/IMDRF and ASEAN AMDD. Your device class determines the registration pathway, documentation requirements, and review timeline.

Class A — Low Risk

Class A Devices

Lowest-risk devices including non-sterile bandages, tongue depressors, wheelchairs, and examination gloves. Class A devices require only a Dealer’s Licence — no separate product registration is needed.

Why is Class A different from other classes?

Class A devices are exempt from product registration under the Health Products (Medical Devices) Regulations 2010. Only a valid Dealer’s Licence (Manufacturer, Importer, or Wholesaler) with GDPMDS certification is required to supply these devices in Singapore.

Class B — Low-Moderate Risk

Class B Devices

Low-moderate risk devices such as blood pressure monitors, pregnancy test kits, surgical gloves, and powered nebulisers. Product registration via SHARE portal is required in addition to a Dealer’s Licence.

What registration routes are available for Class B?

Class B devices can use the Immediate route (1 hour, with 2+ reference agency approvals), Expedited (~90-120 WD), Abridged (~120-270 WD), or Full evaluation (~160-330 WD). Prior approvals from US FDA, EU, Health Canada, TGA, or PMDA determine eligibility.

Class C — Moderate-High Risk

Class C Devices

Moderate-high risk devices including ventilators, orthopaedic implants, haemodialysis equipment, and infusion pumps. Requires full or abridged evaluation with clinical evidence per GN-20.

Is clinical data mandatory for Class C devices?

Yes. Class C devices require clinical evidence per GN-20 demonstrating safety and performance. This may include clinical investigation data, published literature reviews, or equivalence arguments. The level of evidence scales with device risk and novelty.

Class D — Highest Risk

Class D Devices

Highest-risk devices including heart valves, pacemakers, implantable defibrillators, and HIV diagnostic kits. Subject to rigorous full evaluation with priority review available for critical devices.

Can Class D devices get faster approval?

Yes. Class D devices with prior approvals from recognised reference agencies (US FDA, EU, Health Canada, TGA, PMDA) may qualify for the Expedited route (~90-120 WD) instead of Full evaluation (~160-330 WD). Priority review may also be available for devices addressing unmet clinical needs.

Registration Routes

Four Evaluation Routes Based on Reference Agency Approvals

HSA recognises approvals from US FDA, EU Notified Bodies, Health Canada, TGA Australia, and PMDA Japan to determine your fastest path to the Singapore market.

Immediate Route

Registered in 1 Hour

Available for Class B and C devices with approvals from 2 or more reference agencies. Device is registered and listed on the SMDR within 1 hour of a complete SHARE submission.

Expedited Route

~90-120 Working Days

Available for Class B, C, and D devices with 1 or more reference agency approvals. HSA performs a focused review of the CSDT with emphasis on any Singapore-specific requirements.

Abridged Route

~120-270 Working Days

Available for Class B, C, and D devices with 1 or more reference agency approvals. Uses summary-level data in the CSDT rather than full documentation, reducing preparation effort.

Full Evaluation Route

~160-330 Working Days

Required when no reference agency approval exists. Complete ASEAN CSDT with full technical documentation across all 7 chapters. Applicable to all device classes (B, C, D).

Our HSA Services

Comprehensive HSA Registration Services

From initial classification through post-market surveillance, NexorTest manages every aspect of your Singapore regulatory journey.

HSA Device Registration

End-to-end registration via the SHARE portal for Class B, C, and D medical devices. Route determination (Immediate, Expedited, Abridged, or Full), complete ASEAN CSDT dossier preparation, and SMDR listing management.

Local Authorized Representative (ALR)

Appointment and management of a Moroccan Local Authorized Representative with a qualified pharmacist or biomedical engineer on staff, compliant warehouse facilities, and established recall procedures as mandated by Décret 2-14-607.

CE Marking Recognition

Leveraging CE marking acceptance in Morocco's regulatory framework. Preparation and verification of EC certificates, Declarations of Conformity, and all supporting documentation accepted by AMMPS as evidence of conformity for streamlined registration.

Technical File Preparation (French)

Complete technical dossier preparation in French including product specifications, manufacturing process documentation, materials and components lists, risk management file (ISO 14971), clinical evaluation report, and post-market surveillance plan per AMMPS requirements.

ISO 13485 QMS Implementation

Full Quality Management System implementation required for AMMPS dossier submission. Includes gap analysis against ISO 13485:2016, documentation development, process optimization, internal audit support, and coordination with certification bodies.

Clinical Evaluation Reports

Clinical evaluation per Article 15 of Loi 84-12. Literature-based clinical evaluation, clinical investigation support, equivalence assessment for predicate devices, and compilation of clinical evidence packages meeting AMMPS advisory commission requirements.

IVD Registration Morocco

Specialized In Vitro Diagnostic device registration with local technical evaluation. Extended timeline management for IVD categories (up to 12 months), IVD-specific documentation preparation, analytical performance data compilation, and AMMPS IVD submission support.

Import Permit Management

Per-shipment import permit processing with approximately 2-week turnaround per permit. Annual import planning, customs documentation preparation, PortNet platform submissions, warehouse coordination, and ongoing logistics compliance management.

Post-Market Surveillance & Matériovigilance

Comprehensive PMS system setup, adverse event reporting to AMMPS, field safety corrective action management, periodic safety update reports, and ongoing compliance monitoring to maintain your 5-year registration certificate in good standing.

Why NexorTest

Singapore's Trusted HSA Specialist

We combine deep Singapore and ASEAN regulatory expertise with global experience to deliver faster, more predictable HSA approvals.

Singapore & ASEAN Regulatory Specialists

Deep expertise in HSA framework and ASEAN AMDD. CSDT dossiers prepared for Singapore can be adapted for Malaysia (MDA), Thailand (Thai FDA), Philippines (FDA Philippines), and Indonesia (BPOM) — maximising your ASEAN market access from a single submission.

Reference Agency Route Optimisation

We analyse your existing FDA, CE, TGA, Health Canada, or PMDA approvals to determine the fastest registration route. Many clients qualify for Immediate (1 hour) or Expedited (90-120 WD) routes, saving months of review time.

SHARE Portal Expertise

Fully trained on Singapore's new SHARE submission system launched July 2025, ensuring smooth transitions from legacy MEDICS workflows. We manage end-to-end submissions, document uploads, fee processing, and query responses within the platform.

Multi-Region Regulatory Expertise

Simultaneous registrations across HSA, MDA Malaysia, US FDA, EU MDR, CDSCO India, and 30+ markets. One partner for global market access from a single integrated program.

Transparent Pricing & Fixed-Fee Packages

No hidden costs or hourly billing surprises. Our fixed-fee packages cover the complete scope from strategy through SMDR listing, with clear milestones and deliverables.

First Submission Acceptance

0 %

Countries Served

0 +

Faster Than Industry Average

0 %

Our Process

Six Steps to Your HSA Registration

A proven, structured approach that minimises review queries and accelerates your path to the Singapore medical device market.

Device Classification & Route Strategy

We classify your device per GN-13 (general devices) or GN-14 (IVDs) and determine the optimal registration route — Immediate, Expedited, Abridged, or Full — based on your existing reference agency approvals from US FDA, EU, Health Canada, TGA, or PMDA.

Dealer's Licence & GDPMDS

We obtain the appropriate Dealer’s Licence (Manufacturer, Importer, or Wholesaler) with GDPMDS certification from a SAC-accredited Conformity Assessment Body. We verify ACRA registration and ensure your quality system meets all HSA requirements.

ASEAN CSDT Dossier Preparation

We prepare the complete 7-chapter ASEAN Common Submission Dossier Template: administrative information, QMS (ISO 13485), Essential Principles compliance (GN-16), preclinical evidence, clinical evidence (GN-20), labelling (GN-23), and device-specific annexes.

SHARE Portal Submission

We submit the completed application via HSA’s SHARE portal with all applicable fees. HSA performs an administrative screening within approximately 5 working days to verify completeness before technical evaluation commences.

HSA Technical Evaluation & Query Resolution

We navigate the technical review process, respond to stop-clock queries from HSA evaluators promptly, and manage the evaluation timeline per your selected registration route (Immediate, Expedited, Abridged, or Full).

SMDR Listing & Post-Market Compliance

Upon approval, your device is listed on the Singapore Medical Device Register (SMDR). We establish post-market surveillance, adverse event reporting (GN-05), FSCA reporting (GN-10), change notification (GN-21), UDI compliance, and annual retention fee management.

Industries We Serve

HSA Registration Across All Device Sectors

NexorTest supports medical device manufacturers across every therapeutic area and technology vertical entering the Singapore and ASEAN markets.

🏥 Cardiovascular Devices
🦴 Orthopaedic Implants
🔬 In Vitro Diagnostics (IVD)
💻 Software as Medical Device (SaMD)
🧬 Dental Devices
👁 Ophthalmic Devices
🩺 Patient Monitoring Systems
💉 Drug Delivery Devices
🧠 Neurological Devices
❤ Wound Care Products
🏋 Rehabilitation Equipment
💡 AI/ML-Based Medical Devices
🩸 Blood Bank Equipment
📊 Imaging & Radiology Devices
🧪 Laboratory Instruments
🛡 Sterilization Equipment

Frequently Asked Questions

HSA Registration FAQ

Expert answers to the most common questions about medical device registration with HSA Singapore.

What is HSA medical device registration in Singapore?

HSA medical device registration is the mandatory regulatory process governed by the Health Sciences Authority (Medical Device Branch) under Singapore’s Ministry of Health. Under the Health Products Act (Chapter 122D) and the Health Products (Medical Devices) Regulations 2010 (GN S 436/2010), all medical devices supplied in Singapore must comply with HSA requirements. Class A devices require only a Dealer’s Licence, while Class B, C, and D devices require product registration and listing on the Singapore Medical Device Register (SMDR). Applications are submitted through the SHARE portal (Singapore Health Product Access and Regulatory E-System), which replaced the legacy MEDICS system in July 2025. HSA’s classification system is aligned with GHTF/IMDRF and the ASEAN AMDD framework per GN-15 R12. Registration routes include Immediate, Expedited, Abridged, and Full evaluation, with timelines ranging from 1 hour to 330 working days depending on risk class and prior reference agency approvals.

What are the HSA registration routes (Immediate, Expedited, Abridged, Full)?

HSA offers four registration routes based on prior approvals from recognised reference agencies (US FDA, EU Notified Bodies, Health Canada, TGA Australia, PMDA Japan). The Immediate route is available for Class B and C devices with approvals from 2 or more reference agencies — registration is granted within 1 hour. The Expedited route applies to Class B, C, and D devices with 1+ reference agency approvals, taking approximately 90-120 working days. The Abridged route is for Class B, C, and D devices with 1+ reference agency approvals using summary-level data in the CSDT, typically requiring 120-270 working days. The Full evaluation route is for all classes when no reference agency approval exists, requiring a complete ASEAN CSDT with full technical documentation, taking approximately 160-330 working days. NexorTest analyses your existing global approvals to determine the fastest available route and prepares the corresponding dossier for SHARE portal submission.

What is the SHARE submission portal?

SHARE (Singapore Health Product Access and Regulatory E-System) is HSA’s digital submission and regulatory management platform, launched in July 2025 to replace the legacy MEDICS (Medical Device Information and Communication System). SHARE supports the full lifecycle of medical device regulatory interactions including new product registration applications, Dealer’s Licence applications and renewals, change notifications (GN-21), post-market adverse event reporting (GN-05), and annual retention fee payments. The platform features real-time application tracking, secure document management, automated fee calculations, and integrated query response workflows. All new submissions to HSA’s Medical Device Branch must be made through SHARE. NexorTest’s regulatory team is fully trained on the SHARE system and manages the entire submission process on behalf of clients.

How are medical devices classified in Singapore?

Singapore classifies medical devices into four risk-based classes aligned with the GHTF/IMDRF framework and ASEAN Medical Device Directive (AMDD). Classification is governed by GN-13 for general medical devices and GN-14 for IVDs. Class A represents low-risk devices (non-sterile bandages, tongue depressors, wheelchairs) — requiring only a Dealer’s Licence. Class B covers low-moderate risk devices (blood pressure monitors, pregnancy tests, surgical gloves) — product registration required. Class C includes moderate-high risk devices (ventilators, orthopaedic implants, haemodialysis equipment) — full or abridged evaluation. Class D encompasses the highest-risk devices (heart valves, pacemakers, HIV diagnostics) — rigorous assessment required. SaMD is classified per GL-07 (updated July 2025). Classification determines the registration route, documentation depth, clinical evidence requirements, and applicable timelines.

What is a Dealer's Licence and who needs one?

A Dealer’s Licence is mandatory for any entity that manufactures, imports, or wholesales medical devices in Singapore under the Health Products Act. There are three categories: Manufacturer’s Licence, Importer’s Licence, and Wholesaler’s Licence. All licence holders must comply with the Good Distribution Practice for Medical Devices in Singapore (GDPMDS), which requires certification by a SAC-accredited Conformity Assessment Body (CAB). The applicant must also be registered with ACRA (Accounting and Corporate Regulatory Authority of Singapore). For Class A devices, a Dealer’s Licence alone is sufficient — no product registration is needed. For Class B, C, and D devices, both a Dealer’s Licence and product registration are required. Dealer’s Licence applications are submitted via the SHARE portal and are typically processed within 30 working days. NexorTest manages the full application process including GDPMDS certification coordination and SAC-accredited CAB engagement.

How long does HSA registration take?

HSA registration timelines vary by device class and selected registration route. Class A devices require only a Dealer’s Licence, typically processed in 1-2 weeks. Class B devices take 3-6 months depending on the route: Immediate (1 hour with 2+ reference agency approvals), Expedited (~90-120 working days), Abridged (~120-270 working days), or Full (~160-330 working days). Class C devices follow similar routes and typically take 6-12 months. Class D devices undergo the most rigorous assessment, taking 9-18 months for Full evaluation, though Expedited routes can significantly reduce this. All timelines are subject to a 5-working-day administrative screening period after SHARE submission. Stop-clock periods for query responses are excluded from these estimates. NexorTest’s expertise in dossier preparation and query management helps minimise stop-clock delays.

Which reference agencies does HSA recognise?

HSA recognises five reference regulatory agencies whose prior approvals can qualify medical devices for expedited registration routes. These are: US FDA (Food and Drug Administration), EU Notified Bodies (for CE marking under EU MDR/MDD), Health Canada (Medical Devices Bureau), TGA Australia (Therapeutic Goods Administration), and PMDA Japan (Pharmaceuticals and Medical Devices Agency). Devices with approvals from 2 or more reference agencies may qualify for the Immediate route (Class B/C only, registered within 1 hour). Devices with 1 or more reference agency approvals can use the Expedited or Abridged routes per GN-15 R12. NexorTest analyses your existing global regulatory portfolio to identify the optimal HSA route, potentially saving months of review time and reducing documentation requirements significantly.

Can NexorTest help with SaMD and IVD registration in Singapore?

Yes, NexorTest provides specialised HSA registration services for both Software as a Medical Device (SaMD) and In Vitro Diagnostic (IVD) devices in Singapore. For SaMD, we manage classification per GL-07 (updated July 2025), Clinical Decision Support Software (CDSS) qualification, Change Management Program setup per GN-37, and ML-enabled SaMD guidance compliance. We handle the complete software lifecycle documentation including IEC 62304, cybersecurity risk assessments, and clinical evaluation for AI/ML algorithms. For IVDs, we manage classification under GN-14 across Class A through D IVD pathways, prepare analytical performance data packages, coordinate clinical performance studies, and handle SHARE portal submissions. Our team has extensive experience navigating HSA’s technical review processes for both IVD and SaMD categories, ensuring comprehensive ASEAN CSDT dossier preparation that addresses HSA’s specific evidence requirements.

Ready to Enter the Singapore Medical Device Market?

Get a free HSA regulatory assessment from Singapore’s leading medical device registration consultants. Our experts will map your fastest path to SMDR listing.